Princeton Longevity Center’s Cancer Surveillance Program extends advanced cancer screening throughout the year rather than relying on a single point-in-time screening.
Following your initial comprehensive evaluation, this program combines Full Body MRI and Galleri® multi-cancer early detection testing at key intervals throughout the year to provide the most proactive approach to cancer surveillance available.
Baseline Exam
Galleri
Full Body MRI
Galleri
Annual Exam
Day 1:
Your initial CancerCheck Program or Comprehensive Evaluation may include:
3 Months:
A blood test designed to detect a shared signal associated with multiple types of cancer and predict the tissue type or organ associated with the signal.
6 Months:
Repeat imaging of the chest, abdomen and pelvis provides another opportunity to identify concerning findings or changes that may warrant further evaluation.
9 Months:
An additional screening touchpoint between imaging and your next annual evaluation.
12 Months:
Return to Princeton Longevity Center for your next Comprehensive Exam or CancerCheck evaluation and establish your surveillance strategy for the year ahead.
No single screening test can detect every cancer.
Combined with the testing performed during your Princeton Longevity Center exam, this program creates four screening touchpoints throughout the year—providing an added layer of surveillance and greater opportunity to detect a new concern earlier.
The Cancer Surveillance Program may be appropriate for individuals who:
when appropriate in consultation with their treating physicians
Go beyond the annual snapshot.
Important Information: No cancer screening test or surveillance program can detect all cancers or guarantee early detection. The Princeton Longevity Center Cancer Surveillance Program is designed to provide additional opportunities to identify potential signs of cancer through periodic screening throughout the year. Full Body MRI and Galleri® testing have individual limitations and may produce false-positive or false-negative results. Participation in this program does not replace age- and risk-appropriate cancer screenings, diagnostic testing, or care recommended by your treating physicians. Testing recommendations and frequency should be individualized based on your personal and family history, risk factors, and clinical circumstances.